Physician profile
Robert B Scott
NPI 1831113778
$1,319.04
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $53.09 · 2021: $45.07 · 2022: $14.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $182.83 | 2019-2020 | |
| Novo Nordisk INC | $132.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.79 | 2019 | |
| Lilly USA, LLC | $117.07 | 2019 | |
| Amarin Pharma, INC. | $95.31 | 2019 | |
| Abbvie INC. | $84.96 | 2019-2022 | |
| Glaxosmithkline, LLC. | $70.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $54.16 | 2019 | |
| Amgen INC. | $53.96 | 2019 | |
| Astellas Pharma US INC | $48.07 | 2019 | |
| Neotract INC. | $42.55 | 2019 | |
| Pfizer INC. | $35.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.29 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.52 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21.88 | 2019 | |
| Sanofi Pasteur INC. | $20.99 | 2019 | |
| Valeritas, INC. | $19.95 | 2019 | |
| Cranial Technologies, INC | $16.94 | 2019 | |
| Aytu Biopharma, INC. | $16.46 | 2020 | |
| Nevro Corp. | $15.57 | 2019 | |
| Sobi, INC | $13.92 | 2019 | |
| Melinta Therapeutics, LLC | $13.51 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.28 | 2019 | |
| Genentech USA, INC. | $12.93 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.92 | 2019 | |
| Merck Sharp & Dohme LLC | $11.44 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.